GTR Home > Tests > Search results - HSPB1[gene]

Apply filters

Showing tests for all 1697 conditions

Compare labs

Your search term can be found in tests with a total of 1697 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states
More locations

GTR test search results for 3315[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 41 tests for 1697 conditions in 18 labs

CCMT2F

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeuronopathy distal hereditary motor type IIB

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CHSPB1. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CDistal Hereditary Motor Neuropathy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (22)
Total targets (17)

CHeat Shock 27 kDa Protein-Related Disorders via the HSPB1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCharcot-Marie-Tooth (CMT) and Related Hereditary Neuropathies Panel Sequencing

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (34)
Total targets (78)

CCharcot-Marie-Tooth (CMT) and Related Hereditary Neuropathies, PMP22 Deletion/Duplication with Reflex to Sequencing Panel

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (34)
Total targets (78)

CCharcot-Marie-Tooth disease (NGS panel for 43 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Total conditions (24)
Total targets (43)

CHereditary peripheral neuropathies, including Charcot-Marie-Tooth disease (NGS panel for 74 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (74)

CCharcot-Marie-Tooth disease type 2F (CMT2F, sequence analysis of HSPB1 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSpinal Muscular Atrophy (SMA) Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (44)
Total targets (22)

CCharcot-Marie-Tooth and Sensory Neuropathies Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (65)
Total targets (83)

CSpinal Muscular Atrophy Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany

CHereditary Spastic Paraplegias (HSP) and differential diagnoses Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (147)
Total targets (133)

CHSPB1

Test targets
Methods
  • S Mutation scanning of the entire coding region

CNeuropathy

Total conditions (7)
Total targets (122)

Showing 1 to 20 of 41 tests for 1697 conditions in 18 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.